• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Meiragtx Holdings Plc (NQ: MGTX )

    6.920 +0.190 (+2.82%)
    Streaming Delayed Price Updated: 3:56 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Meiragtx Holdings Plc

    < Previous 1 2 3 Next >
    Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good
    SoFi Technologies, Inc. is good, Jim Cramer said. It reported third-quarter adjusted sales of $689.445 million, according to Benzinga Pro. 
    Via Benzinga
    MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress
    Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy Platforms 
    From MeiraGTx
    Via GlobeNewswire
    Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
    Via Benzinga
    Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints
    MeiraGTx's clinical study of AAV-GAD for Parkinson's disease showed significant improvements in motor function and quality of life in high- and low-dose groups, with no serious adverse events.... 
    Via Benzinga
    Recap: MeiraGTx Hldgs Q4 Earnings
    Via Benzinga
    MeiraGTx Hldgs: Q3 Earnings Insights
    Via Benzinga
    Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views
    Via Benzinga
    Exposures Fossil Fuels
    Walgreens Posts Upbeat Earnings, Joins Wolfspeed, Ericsson And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease
    From MeiraGTx
    Via GlobeNewswire
    MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference
    Results indicate a potent and effective locally delivered AAV-BDNF gene therapy for the treatment of obesity caused by MC4R deficiency 
    From MeiraGTx
    Via GlobeNewswire
    MGTX Stock Earnings: MeiraGTx Hldgs Misses EPS, Misses Revenue for Q2 2024
    MGTX stock results show that MeiraGTx Hldgs missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results
    From MeiraGTx
    Via GlobeNewswire
    MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
    From MeiraGTx
    Via GlobeNewswire
    Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
    Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings. 
    Via Benzinga
    MGTX Stock Earnings: MeiraGTx Hldgs Beats EPS, Misses Revenue for Q1 2024
    MGTX stock results show that MeiraGTx Hldgs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    MeiraGTx Reports First Quarter 2024 Financial and Operational Results
    From MeiraGTx
    Via GlobeNewswire
    MeiraGTx to Participate in Upcoming Investor Conferences
    From MeiraGTx
    Via GlobeNewswire
    MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
    From MeiraGTx
    Via GlobeNewswire
    MGTX Stock Earnings: MeiraGTx Hldgs Beats EPS, Misses Revenue for Q4 2023
    MGTX stock results show that MeiraGTx Hldgs beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
    From MeiraGTx
    Via GlobeNewswire
    MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
    MeiraGTx to receive $50 million milestone after initiation of the extension study for the Phase 3 LUMEOS clinical trial for botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of... 
    From MeiraGTx
    Via GlobeNewswire
    Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today?
    MeiraGTx Holdings plc (NASDAQ: MGTX) on Thursday announced an asset purchase agreement with Janssen Pharmaceuticals Inc, a Johnson & Johnson (NYSE: JNJ) compan 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! 
    Via InvestorPlace
    MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
    From MeiraGTx
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    MeiraGTx to Participate in Upcoming Investor Conferences
    From MeiraGTx
    Via GlobeNewswire
    MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
    From MeiraGTx
    Via GlobeNewswire
    BestGrowthStocks.Com: MeiraGTx Holdings plc Actively Pursuing Strategic Partnerships and Asset Interest, Potential Transactions
    Best Growth Stocks, a leading independent research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a... 
    Via TheNewswire.com
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.